In Vivo is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

Jomed NV invests in Pathway Medical and CardioPath

Executive Summary

Jomed NV (IVUS and other MIS vascular interventional technology) has licensed exclusive rights in Europe, Japan, and other world markets outside the US, to Pathway Medical Technologies' CardioPath debulking system, a catheter-based drilling device that opens diseased and clogged arteries and bypass grafts, usually so stents can be placed.
Deal Industry
  • Medical Devices
  • Medical Devices
    • Surgical Equipment & Devices
Deal Status
  • Final
Deal Type
  • Alliance
    • Includes Equity
    • R&D and Marketing (Licensing)

Related Companies